Myeloma CAR T-Therapy Among New EMA PRIME Winners

Janssen, Krystal Biotech and Takeda are the latest companies to win a place on the European Medicines Agency’s popular priority medicines scheme for getting drugs for unmet medical needs through the review process faster.

Priority
Three new investigational drugs have won EU priority status • Source: Shutterstock

More from R&D

More from Pink Sheet